TY - JOUR
T1 - Regulatory factors for luteolysis in ruminants
AU - Schams, Dieter
AU - Berisha, Bajram
PY - 2001
Y1 - 2001
N2 - In ruminants, there is clear evidence that luteal regression at the end of the oestrous cycle is caused by episodic release of prostaglandin F2α (PGF2αJ from the uterus. Experiments demonstrate that exposure to physiological luteal progesterone levels or inhibition of progesterone receptors by antagonist regulates the onset of uterine release of PGF2α pulses for induction of luteolysis, and causes shortening or extension of the interoestrous interval in sheep and cows. There is strong support that vasoconstrictive peptides may play a key role during the luteolytic cascade. Therefore we investigated in detail the real-time changes (corpora lutea were collected before and 2, 4, 12, 24, 48 and 64 h (n=5/phase) after PG analogue injection) in mRNA expression of angiotensin-converting enzyme (ACE), angiotensin-receptors (ATR-1 and ATR-2), endothelin-1 (ET-1), ET receptors (ETR-A and ETR-B), and measured luteal tissue concentrations of angiotensin II (Ang II) and ET-1. ACE and ET-1 mRNA expression and Ang II and ET-1 tissue concentrations increased continuously to maximum levels 24 - 48 h after PG analogue injection and declined thereafter. ETR-A and ETR-B mRNA levels show a similar trend. The ATR-1 mRNA is unchanged and ATR-2 increased after 48 and 64 h. Thus, we propose that PGF2α administration triggers Ang II and ET-I release in corpus luteum (CL), which causes functional luteolysis by suppression of progesterone production and release by vasoconstriction of arteriols and direct effects on luteal cells.
AB - In ruminants, there is clear evidence that luteal regression at the end of the oestrous cycle is caused by episodic release of prostaglandin F2α (PGF2αJ from the uterus. Experiments demonstrate that exposure to physiological luteal progesterone levels or inhibition of progesterone receptors by antagonist regulates the onset of uterine release of PGF2α pulses for induction of luteolysis, and causes shortening or extension of the interoestrous interval in sheep and cows. There is strong support that vasoconstrictive peptides may play a key role during the luteolytic cascade. Therefore we investigated in detail the real-time changes (corpora lutea were collected before and 2, 4, 12, 24, 48 and 64 h (n=5/phase) after PG analogue injection) in mRNA expression of angiotensin-converting enzyme (ACE), angiotensin-receptors (ATR-1 and ATR-2), endothelin-1 (ET-1), ET receptors (ETR-A and ETR-B), and measured luteal tissue concentrations of angiotensin II (Ang II) and ET-1. ACE and ET-1 mRNA expression and Ang II and ET-1 tissue concentrations increased continuously to maximum levels 24 - 48 h after PG analogue injection and declined thereafter. ETR-A and ETR-B mRNA levels show a similar trend. The ATR-1 mRNA is unchanged and ATR-2 increased after 48 and 64 h. Thus, we propose that PGF2α administration triggers Ang II and ET-I release in corpus luteum (CL), which causes functional luteolysis by suppression of progesterone production and release by vasoconstriction of arteriols and direct effects on luteal cells.
KW - Angiotensin II
KW - Endothelin I
KW - Luteolysis
KW - Progesterone action
KW - Ruminant
UR - http://www.scopus.com/inward/record.url?scp=0035616055&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:0035616055
SN - 0003-9438
VL - 44
SP - 51
EP - 53
JO - Archives Animal Breeding
JF - Archives Animal Breeding
IS - SUPPL. 1
ER -